Ixabepilone Completed Phase 1 Trials for Unspecified Adult Solid Tumor, Protocol Specific Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00096317Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors
NCT00004927BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
NCT00043095BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors
NCT00884676Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors